In summary, we reported a novel mechanism underlying AR’s promotion of RCC proliferation and progression by AR protein binding of a pseudogene ASS1P3 to suppress the latter’s ceRNA function, thus releasing miR-34a-5p to inhibit ASS1 expression. The gene discussed is ASS1; the disease is renal cell carcinoma.